Journal of Clinical Pediatrics >
Effect of amnioreduction on maternal polyhydramnios and neonatal death
Received date: 2022-09-26
Online published: 2024-01-05
Objective To analyze the effect of amnioreduction on maternal polyhydramnios induced by fetal gastrointestinal atresia and its influence on neonatal death. Methods The clinical data of pregnant women with polyhydramnios induced by fetal gastrointestinal atresia and the data of their newborns from May 2018 to May 2021 were retrospectively analyzed. According to the treatment methods, the pregnant women were divided into conventional treatment group, diuretic use group and amnioreduction group. The perinatal complications, delivery mode and pregnancy outcome of the three groups were compared, and the influencing factors of neonatal death were analyzed. Results A total of 126 pregnant women with polyhydramnios induced by fetal gastrointestinal atresia were included. There were 65 pregnant women in the conventional treatment group, the average age was (31.0±4.9) years old, and the gestational week of the first treatment was 23-34+6 weeks. In the diuretic use group, the mean age of 31 pregnant women was (29.3±5.2) years old, and the gestational week of the first treatment was 25-34+4 weeks. There were 30 pregnant women in the amnioreduction group, the average age was (31.0±5.3) years old, and the gestational week of the first treatment was 26-34+6 weeks. There were statistically significant differences in the proportion of premature birth and neonatal death among different treatment groups (P<0.05). The preterm birth rate and neonatal death rate were lower in the amnioreduction group. Compared with the survival group, the proportion of cesarean section and amnioreduction was lower, the rate of premature birth was higher in the death group, and the difference was statistically significant (P<0.05). Binary logistic regression analysis showed that premature delivery and conventional treatment without amnioreduction were independent risk factors for neonatal death (P<0.05). Conclusions Amniotic fluid reduction can prolong the gestational weeks of pregnant women with polyhydramnios induced by fetal gastrointestinal atresia, reduce the rate of premature birth and improve the prognosis of newborns.
Jiaying NI , Tao ZHENG , Lei WANG , Wenjuan XIE , Hong ZHU . Effect of amnioreduction on maternal polyhydramnios and neonatal death[J]. Journal of Clinical Pediatrics, 2024 , 42(1) : 40 -45 . DOI: 10.12372/jcp.2024.22e1261
| [1] | Wu X, Li Y, Lin N, et al. Evaluation of genetic variants using chromosomal microarray analysis for fetuses with polyhydramnios[J]. BMC Med Genomics, 2022, 15(1): 73. |
| [2] | Deng L, Cheung SW, Schmitt ES, et al. Targeted gene panel sequencing prenatally detects two novel mutations of DYNC2H1 in a fetus with increased biparietal diameter and polyhydramnios[J]. Birth Defects Res, 2018, 110(4): 364-371. |
| [3] | Preda A, ?tefan AG, Preda SD, et al. Transient poly-hydramnios during pregnancy complicated with gestational diabetes mellitus: case report and systematic review[J]. Kazemi S, Diagnostics (Basel), 2022, 12(6): 1340. |
| [4] | Soleimani F, Kazemi S, Kazemnezhad A, et al. Perinatal outcomes of idiopathic polyhydramnios with normal ultrasound: a systematic review and meta-analysis[J]. Int J Pediatr, 2019, 7(5): 9349-9362. |
| [5] | 任静, 陈爱军, 李扬, 等. 超声诊断单纯性羊水过多在评价胎儿畸形、宫内转归及预后中的价值[J]. 中国妇幼保健, 2017, 32(5): 1064-1066. |
| [6] | Simmons PM, Whittington JR, Estrada SM, et al. What is the impact of abnormal amniotic fluid volumes on perinatal outcomes in normal compared with at-risk pregnancies?[J]. Int J Womens Health, 2020, 12: 805-812. |
| [7] | Vanda R, Bazrafkan M, Rouhani M, et al. Comparing pregnancy, childbirth, and neonatal outcomes in women with idiopathic polyhydramnios: a prospective cohort study[J]. BMC Pregnancy Childbirth, 2022, 22(1): 399. |
| [8] | Kraus A, Kucirka L, Shah H, et al. Maximum vertical pocket versus amniotic fluid index: assessing adverse pregnancy outcomes in patients with polyhydramnios[J]. Am J Obstet Gynecol, 2022, 226(1): S314-S315. |
| [9] | Litwinska E, Litwinska M, Czuba B, et al. Amniocentesis in twin pregnancies: risk factors of fetal loss[J]. J Clin Med, 2022, 11(7): 1937. |
| [10] | Salomon LJ, Sotiriadis A, Wulff CB, et al. Risk of miscarriage following amniocentesis or chorionic villus sampling: systematic review of literature and updated meta-analysis[J]. Ultrasound Obstet Gynecol, 2019, 54(4): 442-451. |
| [11] | 王跃旗, 李春燕, 王亚荀, 等. 宣肺利水固本方治疗特发性羊水过多72例临床研究[J]. 四川中医, 2020, 38(11): 167-170. |
| [12] | 蔡威, 孙宁, 魏光辉. 小儿外科学[M]. 5版. 北京: 人民卫生出版社, 2014: 476-479. |
| [13] | 芦金玲, 姚升郊, 刘娜. 孕妇血LBP、sPLA2、IL-8水平变化及诊断胎膜早破合并宫内感染价值[J]. 中国计划生育学杂志, 2022, 30(10): 2378-2381. |
| [14] | 梁秋霞, 翁廷松, 卢荔婕, 等. 产妇产后出血的危险因素分析及基于循证医学的预警信息系统构建[J]. 中国性科学, 2021, 30(6): 80-84. |
| [15] | 周斌, 梁菁苹, 丁仁波, 等. 血清TNF-α与Npt和G-CSF对胎膜早破合并羊膜腔感染的诊断分析[J]. 中华医院感染学杂志, 2017, 27(19): 4504-4506. |
| [16] | Pagan M, Magann EF, Rabie N, et al. Idiopathic polyhydramnios and pregnancy outcome: systematic review and meta-analysis[J]. Ultrasound Obstet Gynecol, 2023, 61(3): 302-309. |
| [17] | Simonyi A, Eros FR, Hajdu J, et al. Effectiveness of fetal ultrasound diagnostics in cardiac malformations and association with polyhydramnios and oligohydramnios[J]. Quant Imaging Med Surg, 2021, 11(7): 2994-3004. |
| [18] | González-Fernández D, Sahajpal R, Chagüendo JE, et al. Associations of history of displacement, food insecurity, and stress with maternal-fetal health in a conflict zone: a case study[J]. Front Public Health, 2020, 8: 319. |
| [19] | 季华, 胡哓梅, 侯秀红, 等. 中药补气健脾利水治疗羊水过多的临床疗效[J]. 山西医药杂志, 2021, 50(3): 388-390. |
| [20] | Pillai VC, Shah M, Rytting E, et al. Prediction of maternal and fetal pharmacokinetics of indomethacin in pregnancy[J]. Br J Clin Pharmacol, 2022, 88(1): 271-281. |
| [21] | 郑芳秀, 史烨, 陆蓓亦, 等. 不同羊膜腔穿刺指征的胎儿染色体异常核型分析[J]. 中国现代医学杂志, 2018, 28(23): 119-121. |
| [22] | Ramirez-Abarca TG, Gallardo-Gaona JM, Lumbreras-Marquez MI, et al. Amniocentesis learning curve using a low-cost simulation model to teach maternal-fetal medicine fellows[J]. Int J Gynaecol Obstet, 2021, 153(1): 95-99. |
| [23] | Erfani H, Diaz-Rodriguez GE, Aalipour S, et al. Amnioreduction in cases of polyhydramnios: indications and outcomes in singleton pregnancies without fetal interventions[J]. Eur J Obstet Gynecol Reprod Biol, 2019, 241: 126-128. |
| [24] | 蒋梅, 毕伟红. 醛固酮受体拮抗剂对维持性血液透析患者心血管系统的影响[J]. 临床肾脏病杂志, 2020, 20(3): 239-242. |
| [25] | 张周沧, 丁云飞, 杜凯强, 等. 袢利尿剂对有残余肾功能的维持性血液透析患者容量负荷影响的初步研究[J]. 中国血液净化, 2021, 20(1): 1-5. |
| [26] | Ravi S, Allirathinam A, Priya S, et al. Normal and abnormal liquor volume and its correlation with perinatal outcome[J]. The New Indian Journal of OBGYN, 2019, 5(2): 113-119. |
| [27] | Katsura D, Takahashi Y, Iwagaki S, et al. Changes in the intra-amniotic pressure following transabdominal amnioinfusion during pregnancy[J]. Biomed Hub, 2021, 6(3): 86-91. |
| [28] | Hromadnikova I, Kotlabova K, Dvorakova L, et al. Maternal cardiovascular risk assessment 3-to-11 years postpartum in relation to previous occurrence of pregnancy-related complications[J]. J Clin Med, 2019, 8(4): 544. |
| [29] | Kleine RT, Bernardes LS, Carvalho MA, et al. Pregnancy outcomes in severe polyhydramnios: no increase in risk in patients needing amnioreduction for maternal pain or respiratory distress[J]. J Matern Fetal Neonatal Med, 2016, 29(24): 4031-4034. |
| [30] | Mengistu BA, Yismaw AE, Azene ZN, et al. Incidence and predictors of neonatal mortality among neonates admitted in Amhara regional state referral hospitals, Ethiopia: prospective follow up study[J]. BMC Pediatr, 2020, 20(1): 142. |
/
| 〈 |
|
〉 |
